Services
Investment Banking
Equity Research
Capital Markets
Wealth Management
About
Leadership
Locations
Our History
Transactions
Resources
Press Releases
Company News
Login
Wealthscape
Research Portal
Transaction InformationUroGen Pharma Ltd. (Nasdaq: URGN) announced the pricing of an underwritten public offering of... Continue Reading
Transaction Information Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet") announced... Continue Reading
Ladenburg Thalmann served as Lead Bookrunner for this offering. Since 2017, Ladenburg has led 60 fixed income... Continue Reading
Transaction Information Calidi Biotherapeutics, Inc. (NYSE American: CLDI or "Calidi") announced the closing of its... Continue Reading
Ladenburg also acts as Exclusive Advisor for In-License of Phase 3 Ready Asset, eRapa for Familial Adenomatous... Continue Reading
Transaction Information Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company") announced the... Continue Reading
Transaction Information Palisade Bio, Inc. (Nasdaq: PALI) announced that it has closed its private placement with... Continue Reading
Transaction Information Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company") announced an... Continue Reading
Transaction Information Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company") announced the closing of its... Continue Reading